Keyphrases
Active Surveillance
11%
Acute Hospital
50%
Antimicrobial
9%
Antimicrobial Use
18%
Bacteremia
18%
Bloodstream Infection
20%
Carbapenem Resistance
12%
Carbapenem-resistant Acinetobacter Baumannii
38%
Carbapenem-resistant Enterobacteriaceae
30%
Carbapenemase Genes
15%
Carbapenemase-producing Enterobacterales
15%
Carbapenemases
16%
Catheter-associated Urinary Tract Infection (CAUTI)
11%
Central Line-associated Bloodstream Infection (CLABSI)
18%
Clostridium Difficile Infection
14%
Community-acquired Bloodstream Infection
15%
Contact Precautions
12%
COVID-19
16%
Healthcare Workers
32%
Hospital-acquired
9%
Hospital-acquired Urinary Tract Infection
15%
Hospitalized Patients
22%
HVISA
15%
Infection Control
14%
Infection Prevention
11%
Infection Rate
9%
Intensive Care Unit
17%
Israel
100%
Israeli
44%
Klebsiella Pneumoniae (K. pneumoniae)
24%
Klebsiella Pneumoniae Carbapenemase
32%
KPC-2
16%
Long-term Care Facilities
19%
Methicillin-resistant S. Aureus
29%
Methicillin-resistant Staphylococcus Aureus
16%
Ministry of Health
9%
National Policy
15%
National Survey
16%
Odds Ratio
16%
Post-acute Care
38%
Post-acute Care Facilities
11%
Prevention Practices
15%
Preventive Measures
19%
Quantitative PCR
9%
Rapid Detection
15%
Staphylococcus Aureus Bacteremia
16%
Streptococcus Pneumoniae
15%
Tertiary Care Hospital
18%
Vancomycin-intermediate Staphylococcus Aureus
23%
West Nile Fever
15%
Medicine and Dentistry
Acinetobacter Baumannii
23%
Antibiotic Therapy
9%
Antibiotics
9%
Antiinfective Agent
26%
Asymptomatic Bacteriuria
7%
Bacterium Culture
7%
Bloodstream Infection
39%
Boric Acid
7%
Burkholderia cenocepacia
7%
Carbapenem
38%
Carbapenem-Resistant Enterobacteriaceae
15%
Carbapenemase
8%
Case Fatality Rate
7%
Case-Control Study
10%
Catheter Infection
17%
Clostridium Difficile Infection
15%
Cohort Effect
9%
COVID-19
12%
Cross Sectional Study
7%
Emergency Care
16%
Fourier Transform Infrared Spectroscopy
8%
Fulminant
7%
Granulomatous Mastitis
7%
Hand Hygiene
7%
Handwashing
7%
Health Care
17%
Healthcare Associated Infection
8%
Hospital Cost
7%
Infection
23%
Infection Control
15%
Infection Prevention
11%
Intensive Care Unit
23%
Klebsiella pneumoniae
23%
Long-Term Care
11%
Methicillin Resistant Staphylococcus Aureus
15%
Meticillin
7%
Oncology
7%
Pathogen
8%
Peptoclostridium difficile
7%
Pneumococcal Pneumonia
15%
Prevalence
11%
Quinolone Derivative
12%
Respiratory Tract Infection
7%
Single Drug Dose
7%
Staphylococcus Aureus
7%
Streptococcus pneumonia
15%
Subacute Care
25%
Tracheostomy
7%
Urinary System
7%
West Nile Fever
7%